REGENERON

FDA Approved Biologics and Pending Applications

Arcalyst®

rilonacept
BL 125249

Dupixent®

dupilumab
BL 761055

Evkeeza®

evinacumab-dgnb
BL 761181

Eylea®

aflibercept
BL 125387

Eylea® HD

aflibercept
BL 761355

Inmazeb®

atoltivimab; odesivimab; maftivimab
BL 761169

Libtayo®

cemiplimab-rwlc
BL 761097

Veopoz

pozelimab-bbfg
BL 761339

Inter Partes Review Proceedings

DUPIXENTIPR2017-01129
IPR2017-01879
IPR2017-01884
EYLEAIPR2020-01317
IPR2020-01318
IPR2020-01320
IPR2021-00402
IPR2021-00816
IPR2021-00880
IPR2021-00881
IPR2022-00257
IPR2022-00258
IPR2022-00298
IPR2022-00301
IPR2022-01225
IPR2022-01226
IPR2022-01524
IPR2023-00099
IPR2023-00442
IPR2023-00462
IPR2023-00532
IPR2023-00533
IPR2023-00566
IPR2023-00620
IPR2023-00739
IPR2023-00884
IPR2023-01312
IPR2024-00201
IPR2024-00260
IPR2024-00298
IPR2025-00176
IPR2025-00233
IPR2025-00456
PGR2021-00035
PGR2021-00117
GENENTECH CABILLYIPR2015-01624
EYLEA / AHZANTIVEIPR2025-00233
EYLEA / CT-P42IPR2022-00257
IPR2022-00258
IPR2023-00462
IPR2023-00532
IPR2023-00533
IPR2023-00620
IPR2024-00260
IPR2025-00456
PGR2021-00117
EYLEA / LUCENTISIPR2020-01317
IPR2020-01318
IPR2020-01320
IPR2021-00816
EYLEA / OPUVIZIPR2023-00442
IPR2023-00566
IPR2023-00739
IPR2023-00884
IPR2023-01312
IPR2025-00176
EYLEA / YESAFILIIPR2021-00880
IPR2021-00881
IPR2022-01225
IPR2022-01226
IPR2023-00099
IPR2024-00201
IPR2024-00298

U.S. Patent Litigations

DUPIXENT1:17-cv-10465 (D. Mass.)
2:17-cv-02613 (C.D. Cal.)
ZALTRAP1:18-cv-02434 (S.D.N.Y.)
7:11-cv-09463 (S.D.N.Y.)
EYLEA / AHZANTIVE1:23-cv-00097 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.)
EYLEA / CT-P421:23-cv-00089 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.)
1:24-cv-00053 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.)
EYLEA / ENZEEVU1:24-cv-00085 (N.D.W. Va.) (transferred from 2:24-cv-08760 (D.N.J.)) / MDL 1:24-md-03103 (N.D.W. Va.)
EYLEA / LUCENTIS1:18-cv-02434 (S.D.N.Y.)
1:20-cv-00690 (N.D.N.Y.)
EYLEA / LUCENTIS / ZALTRAP1:18-cv-02434 (S.D.N.Y.)
EYLEA / OPUVIZ1:23-cv-00094 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.)
1:23-cv-00106 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.)
EYLEA / PAVBLU1:24-cv-00039 (N.D.W. Va.) (transferred from 1:24-cv-00264 (C.D. Cal.)) / MDL 1:24-md-03103 (N.D.W. Va.)
2:25-cv-05499 (C.D. Cal.)
EYLEA / YESAFILI1:22-cv-00061 (N.D.W. Va.) / MDL 1:24-md-03103 (N.D.W. Va.)
PRALUENT / GENENTECH CABILLY2:15-cv-05685 (C.D. Cal.)
PRALUENT / REPATHA1:14-cv-01317 (D. Del.)
1:14-cv-01349 (D. Del.)
1:14-cv-01393 (D. Del.)
1:14-cv-01414 (D. Del.)